Major Milestone For SK Biopharm As Anti-Epileptic Gets US Approval

 
• By Jung Won Shin
  
MRI
SK's New Treatment Option For Refractory Epilepsy To Launch In 2020 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip